Trial site
San Luis Potosí City
- 11running trials
- 4closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- Lung cancer3 trials
- Chronic kidney disease2 trials
- Heart failure2 trials
- Lupus (SLE)2 trials
- Systemic sclerosis (scleroderma)2 trials
- Atrial fibrillation1 trial
- Endometrial cancer1 trial
- High blood pressure1 trial
- Liver and biliary tract cancer1 trial
- Rheumatoid arthritis1 trial
- Type 2 diabetes1 trial
- Ventricular tachycardia1 trial
- Phase
- Phase 313 trials
- Phase 22 trials
- Status
- Active, not recruiting7 trials
- Not yet recruiting3 trials
- Terminated2 trials
- Withdrawn2 trials
- Recruiting1 trial
- Lead sponsor
- AstraZeneca15 trials
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY)
Active, not recruiting
Active, not recruiting
Active, not recruiting
Phase 3 Study of Anifrolumab in Adult Patients With Active Proliferative Lupus Nephritis
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Durvalumab as Consolidation Therapy in Non-Small Cell Lung Cancer Patients
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- Heart failure1 recruiting
- High blood pressure1 recruiting
- Lupus (SLE)1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Type 2 diabetes1 recruiting
Closed trials
Recruiting
A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis
Recruiting
Terminated
Terminated
Site data: ClinicalTrials.govUpdated 13 Nov 2026